临床营养市场：按营养类型、应用、年龄层、分销管道和地区划分

2025 年全球临床营养市场规模估计为 131.5 亿美元，预计 2032 年将达到 197.7 亿美元，2025 年至 2032 年的年复合成长率(CAGR)为 6.0%。

数字。 2025年各地区临床营养市场占有率（%）

临床营养是指为急性病和营养不良患者或因特殊疾病需要改变日常饮食的患者提供专门的营养支持。这包括对患者营养需求的评估、诊断、介入和监测。临床营养可以治疗多种影响食物摄取和营养吸收的疾病，例如癌症、神经系统疾病、胃肠道疾病、伤口或损伤。它在减少疾病併发症、支持癒合过程以及改善患者的治疗效果和復原时间方面发挥着至关重要的作用。由于全球慢性病的流行和老年人口的增加，过去十年对专业临床营养的需求不断增加。

市场动态：

全球临床营养市场的成长受到老年人口的增长、慢性病和文明病的患病率的增加、居家照护和医疗保健环境中对营养产品的需求的增加以及婴儿营养研发设施的推出等因素的推动。然而，临床营养治疗意识低下和严格的法律规范等因素正在限制市场的成长。基于个人基因图谱的个人化营养产品的开发正在为市场相关人员创造机会。此外，在肿瘤学和神经病学等新治疗领域中，肠内和肠外营养的应用研究日益增多，也预示着良好的前景。

例如，有机婴儿奶粉公司 Bobbie Baby 于 10 月宣布正式推出Bobbie Labs，这是一个专注于婴儿营养的研发中心。 Bobbi Labs 是该公司承诺在 2030 年投资 1 亿美元扩大美国奶粉的取得、品质和选择范围的核心部分。

本研究的主要特点

• 本报告对全球临床营养市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
• 它揭示了各个领域的潜在收益成长机会，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球临床营养市场的主要企业根据以下参数进行分析，例如公司亮点、产品系列、主要亮点、财务表现和策略。
• 研究涉及的主要企业包括雅培 (Abbott)、百特 (Baxter)、费森尤斯 (Fresenius SE &Co.KGaA)、Persanfarma、龙沙 (Lonza)、B. Braun SE、雀巢 (Nestle)、达能 (Danone SA)、百利高 (Perrigo Company plc)、Cestle)、达能 (Danone SA)、百利高 (Perrigo Company plc)、贝里夫集团 (RickSF) 和大良利集团时 (RBAgo Company plc)、大公素集团时(BASF ) 和大良利集团时 (RBAgo Company)、大公素集团（RwC） (Otsuka Pharmaceutical)。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球临床营养市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球临床营养市场的各种策略矩阵来促进决策。

目录：

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

4. 全球临床营养市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年全球临床营养市场（依营养类型划分）

• 经肠营养
• 经肠营养

6. 全球临床营养市场（按应用），2020-2032

• 癌症
• 代谢紊乱
• 胃肠道疾病
• 神经系统疾病
• 其他的

7. 全球临床营养市场（依年龄层划分），2020-2032 年

• 成人
• 孩子们
• 老年人

8. 全球临床营养市场（依分销管道划分），2020-2032 年

• 医院药房
• 零售药局
• 网路药局

9. 全球临床营养市场（按地区划分），2020-2032 年

• 北美洲
• 欧洲
• 亚太地区
• 日本
• 印度
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 拉丁美洲
• 中东
• 非洲

第十章 竞争格局

• Abbott
• Baxter
• Fresenius SE & Co. KGaA
• Persanfarma
• Lonza
• B.Braun SE
• Nestle
• Danone SA
• Perrigo Company plc
• BASF SE
• Reckitt Benckiser Group PLC.
• Otsuka Pharmaceutical Co., Ltd

第 11 章 章节

• 调查方法
• 关于出版商

Global Clinical Nutrition Market is estimated to be valued at USD 13.15 Bn in 2025 and is expected to reach USD 19.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Figure. Clinical Nutrition Market Share (%), By Region 2025

Clinical nutrition refers to the specialized nutrition support provided to patients who are acutely ill and malnourished or have specific medical conditions requiring modifications to their usual diet. It involves the assessment, diagnosis, intervention, and monitoring of patients' nutritional needs. Clinical nutrition enables the management of various conditions like cancer, neurological disorders, gastrointestinal diseases, wounds, or injuries that impact dietary intake and nutrient absorption. It plays a vital role in reducing disease complications, supporting healing processes, and improving treatment outcomes and recovery times of patients. The widespread prevalence of chronic diseases and rising elderly population worldwide have increased the demand for specialized clinical nutrition over the past decade.

Market Dynamics:

The growth of the global clinical nutrition market is driven by the rising geriatric population, increasing prevalence of chronic and lifestyle diseases, growing demand for nutritional products in homecare and healthcare settings, and the launch of research and development facilities for infant nutrition. However, factors like limited awareness regarding clinical nutrition therapy and stringent regulatory framework are restraining the market growth. The development of personalized nutritional products based on an individual's genetic profile is paving opportunities for market players. Also, growing research on using enteral and parenteral nutrition in new therapeutic areas like oncology and neurology presents a lucrative outlook.

For instance, in October, Bobbie Baby, an organic infant formula company, announced the official launch of Bobbie Labs, its research and development hub, dedicated to infant feeding. Bobbie Labs is a core element of the company's commitment to invest US$ 100 million to increase infant formula access, quality, and options for all U.S. families by 2030.

Key Features of the Study:

• This report provides an in-depth analysis of the global clinical nutrition market, and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global clinical nutrition market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Abbott, Baxter, Fresenius SE & Co. KGaA, Persanfarma, Lonza, B. Braun SE, Nestle, Danone S.A., Perrigo Company plc, BASF SE, Reckitt Benckiser Group PLC., and Otsuka Pharmaceutical Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global clinical nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical nutrition market

Detailed Segmentation:

• By Nutrition Type:
  • Enteral Nutrition
  • Parenteral Nutrition
• By Application:
  • Cancer
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others
• By Age Group:
  • Adult
  • Pediatric
  • Geriatric
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Abbott
  • Baxter
  • Fresenius SE & Co. KGaA
  • Persanfarma
  • Lonza
  • B.Braun SE
  • Nestle
  • Danone S.A.
  • Perrigo Company plc
  • BASF SE
  • Reckitt Benckiser Group PLC.
  • Otsuka Pharmaceutical Co., Ltd

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Clinical Nutrition Market, By Nutrition Type
  • Global Clinical Nutrition Market, By Application
  • Global Clinical Nutrition Market, By Age Group
  • Global Clinical Nutrition Market, By Distribution Channel
  • Global Clinical Nutrition Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Clinical Nutrition Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Clinical Nutrition Market, By Nutrition Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Enteral Nutrition
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Parenteral Nutrition
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Clinical Nutrition Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Metabolic Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Gastrointestinal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Clinical Nutrition Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Clinical Nutrition Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Clinical Nutrition Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  • China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius SE & Co. KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Persanfarma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lonza
• B.Braun SE
• Nestle
• Danone S.A.
• Perrigo Company plc
• BASF SE
• Reckitt Benckiser Group PLC.
• Otsuka Pharmaceutical Co., Ltd

11. Section

• Research Methodology
• About us